Clinical and research tests for C0017638 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

<< First< Prev

Page 1 of 2

Results: 1 to 20 of 23

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
OnkoRisk Hereditary Oncology Plus Panel BioReference Health United States	97	77	C Sequence analysis of the entire coding region
OnkoRisk Women's Hereditary Cancer Panel BioReference Health United States	34	18	C Sequence analysis of the entire coding region
IDH1 IDH2 Individual Marker, Brain Cancer GoPath Diagnostics United States	1	2	C Sequence analysis of the entire coding region
CNS Tumor Classification by Methylation Array Institute for Genomic Medicine (IGM) Clinical Laboratory Nationwide Children's Hospital United States	9	2	M Methylation analysis
Cancer Hotspot Panel Genome-Nilou Lab Iran	45	34	E Sequence analysis of select exons
Endeavor PathGroup United States	73	505	C Sequence analysis of the entire coding region
IDH1 and IDH2 Mutation Analysis PathGroup United States	5	2	T Targeted variant analysis
PIK3CA variant detection Laboratory for Molecular Pediatric Pathology Boston Children's Hospital United States	3	1	T Targeted variant analysis
BRAF V600E variant detection Laboratory for Molecular Pediatric Pathology Boston Children's Hospital United States	4	1	T Targeted variant analysis
PrimBio Cancer HotSpot Panel PrimBio Research Institute United States	60	50	T Targeted variant analysis
Comprehensive Panel for Individualized Cancer Threatment GeneKor MSA Greece	16	52	D Deletion/duplication analysis X Mutation scanning of select exons E Sequence analysis of select exons T Targeted variant analysis
Detection by FISH of del1p/del19q CGC Genetics Unilabs Portugal	1	1	F Fluorescence in situ hybridization (FISH)
OnkoSight Advanced CNS NGS BioReference Health United States	1	30	C Sequence analysis of the entire coding region
TERT Promoter Mutation Analysis Molecular Oncology Laboratory, LabCorp United States	2	2	T Targeted variant analysis
1p19q Deletion by FISH and IDH1 R132H Point Mutation by Immunohistochemistry with Reflex to IDH1 and IDH2 Mutation Analysis, Exon 4 ARUP Laboratories, Molecular Oncology ARUP Laboratories United States	2	2	I Immunohistochemistry E Sequence analysis of select exons
IDH1 R132H Point Mutation by Immunohistochemistry with Reflex to IDH1 and IDH2 Mutation Analysis, Exon 4 ARUP Laboratories, Molecular Oncology ARUP Laboratories United States	2	2	I Immunohistochemistry E Sequence analysis of select exons
NeoTYPE® Brain Tumor Profile NeoGenomics Laboratories NeoGenomics Laboratories, Inc. United States	1	47	F Fluorescence in situ hybridization (FISH) C Sequence analysis of the entire coding region
MGMT Promoter Methylation Detection by ddPCR ARUP Laboratories, Molecular Oncology ARUP Laboratories United States	1	1	M Methylation analysis
IDH1 and IDH2 Mutation Analysis Exon 4, Formalin-Fixed, Paraffin-Embedded (FFPE) Tissue ARUP Laboratories, Molecular Oncology ARUP Laboratories United States	1	2	T Targeted variant analysis
IDH1/IDH2 Mutation Analysis Molecular Oncology Laboratory, LabCorp United States	2	2	T Targeted variant analysis

<< First< Prev

Page 1 of 2

Results: 1 to 20 of 23

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.